Phase 1 Clinical Trials and ePRO:
The Time is Now
Download this free whitepaper to learn how Clinical Ink’s ePRO technology, Engage, brings a timely, easy-to-implement, cost-effective solution to Phase 1 studies.
What you'll find in this case study
This free whitepaper will demonstrate how Clinical Ink’s ePRO technology, Engage, can solve long-standing issues with paper-based Phase I clinical trials, including the lack of data attributability, the inability to monitor patient activity in real-time and the time it takes to transcribe subject reported data into an ECF.
Read this whitepaper to learn how Engage revolutionizes Phase I trials with:
- Timely, quality results that save on study budgets
- A tested BYOD option
- An ePRO library with re-usable questionnaires
- Better, cleaner data with a back-end database
- Agile project management and software configuration methodology